373 related articles for article (PubMed ID: 8149362)
1. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
2. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
Huang LG; Bowden CL
J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
[TBL] [Abstract][Full Text] [Related]
3. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
[TBL] [Abstract][Full Text] [Related]
4. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
[TBL] [Abstract][Full Text] [Related]
5. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Kemali D; Maj M; Ariano MG; Salvati A
Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
[TBL] [Abstract][Full Text] [Related]
6. Delusional misidentification and platelet monoamine oxidase.
Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
[TBL] [Abstract][Full Text] [Related]
7. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
[TBL] [Abstract][Full Text] [Related]
8. Platelet monoamine oxidase activity in schizophrenia: a review of the data.
Wyatt RJ; Potkin SG; Murphy DL
Am J Psychiatry; 1979 Apr; 136(4A):377-85. PubMed ID: 371419
[TBL] [Abstract][Full Text] [Related]
9. Effects of neuroleptics on platelet monoamine oxidase activity.
Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
[TBL] [Abstract][Full Text] [Related]
10. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
Bailey AR; Crow TJ; Johnstone EC; Owen F
Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
[No Abstract] [Full Text] [Related]
11. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
[No Abstract] [Full Text] [Related]
12. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
[TBL] [Abstract][Full Text] [Related]
13. [A long-term observation of the platelet monoamine oxidase activity in schizophrenic patients (author's transl)].
Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
Seishin Shinkeigaku Zasshi; 1978 Mar; 80(3):121-4. PubMed ID: 662975
[No Abstract] [Full Text] [Related]
14. Platelet monoamine oxidase activity in acute schizophrenia.
Carpenter WT; Murphy DL; Wyatt RJ
Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
[TBL] [Abstract][Full Text] [Related]
15. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
Meltzer HY; Stahl SM
Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
[No Abstract] [Full Text] [Related]
16. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
Freed WJ; Kleinman JE; Karson CN; Potkin SG; Murphy DL; Wyatt RJ
Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
[No Abstract] [Full Text] [Related]
17. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
Marcolin MA; Davis JM
Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
[TBL] [Abstract][Full Text] [Related]
18. Kinetic constants of platelet monoamine oxidase in schizophrenia.
Jackman HL; Meltzer HY
Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
[TBL] [Abstract][Full Text] [Related]
19. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
Takahashi S; Yamane H; Tani N
Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
[TBL] [Abstract][Full Text] [Related]
20. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
